DK1255754T3 - Linezolid-krystalform II - Google Patents

Linezolid-krystalform II

Info

Publication number
DK1255754T3
DK1255754T3 DK01904805T DK01904805T DK1255754T3 DK 1255754 T3 DK1255754 T3 DK 1255754T3 DK 01904805 T DK01904805 T DK 01904805T DK 01904805 T DK01904805 T DK 01904805T DK 1255754 T3 DK1255754 T3 DK 1255754T3
Authority
DK
Denmark
Prior art keywords
crystal form
linezolid crystal
linezolid
crystal
Prior art date
Application number
DK01904805T
Other languages
English (en)
Inventor
Michael S Bergren
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22658183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1255754(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1255754T3 publication Critical patent/DK1255754T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DK01904805T 2000-02-02 2001-01-29 Linezolid-krystalform II DK1255754T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17983700P 2000-02-02 2000-02-02
EP01904805A EP1255754B1 (en) 2000-02-02 2001-01-29 Linezolid-crystal form ii
PCT/US2001/000657 WO2001057035A1 (en) 2000-02-02 2001-01-29 Linezolid-crystal form ii

Publications (1)

Publication Number Publication Date
DK1255754T3 true DK1255754T3 (da) 2005-08-22

Family

ID=22658183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01904805T DK1255754T3 (da) 2000-02-02 2001-01-29 Linezolid-krystalform II

Country Status (31)

Country Link
EP (1) EP1255754B1 (da)
JP (1) JP5235256B2 (da)
KR (3) KR100864745B1 (da)
CN (1) CN1221547C (da)
AR (1) AR027261A1 (da)
AT (1) ATE297920T1 (da)
AU (1) AU782138B2 (da)
BR (1) BR0107667A (da)
CA (1) CA2395603C (da)
CO (1) CO5261555A1 (da)
CZ (1) CZ302292B6 (da)
DE (1) DE60111497T2 (da)
DK (1) DK1255754T3 (da)
EA (1) EA004434B1 (da)
EE (1) EE05197B1 (da)
ES (1) ES2242728T3 (da)
HK (1) HK1051196A1 (da)
HU (1) HUP0301076A3 (da)
IL (1) IL151010A0 (da)
MX (1) MXPA02007471A (da)
MY (1) MY122829A (da)
NO (2) NO323459B1 (da)
NZ (1) NZ520541A (da)
PE (1) PE20011086A1 (da)
PL (1) PL356433A1 (da)
PT (1) PT1255754E (da)
SI (1) SI1255754T1 (da)
SK (1) SK287025B6 (da)
TW (1) TWI297687B (da)
WO (1) WO2001057035A1 (da)
ZA (1) ZA200205162B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490643B1 (ko) * 2002-10-29 2005-05-19 한국과학기술연구원 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
ES2331001T3 (es) 2003-10-16 2009-12-18 Symed Labs Limited Forma cristalina de linezolid.
EP1737850B1 (en) 2004-04-19 2007-10-03 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
MX2007000084A (es) * 2004-06-29 2007-06-14 Teva Pharma Formas solidas de linezolid y procesos para la preparacion delas mismas.
JP2007504173A (ja) * 2004-06-29 2007-03-01 テバ ファーマシューティカル インダストリーズ リミティド リネゾリドのｉｖ型結晶
JP2008530028A (ja) 2005-02-24 2008-08-07 テバ ファーマシューティカル インダストリーズ リミティド リネゾリッド中間体の調製方法
WO2007002314A2 (en) * 2005-06-22 2007-01-04 Teva Pharmaceutical Industries Ltd. Polymorphic forms of tegaserod maleate
DE602006001699D1 (de) * 2005-07-20 2008-08-21 Teva Pharma Stabile pharmazeutische Zusammensetzung mit Linezolid Form IV
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
CA2703011A1 (en) * 2006-10-23 2008-10-23 Concert Pharmaceuticals Inc. Oxazolidinone derivatives and methods of use
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
AU2011245302A1 (en) 2010-04-30 2012-11-22 Indiana University Research And Technology Corporation Processes for preparing linezolid
EP2603506A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
EP2603505A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
WO2012114354A1 (en) * 2011-02-24 2012-08-30 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
WO2012119653A1 (en) 2011-03-09 2012-09-13 Synthon Bv Process for making crystalline form a of linezolid
CN102731341A (zh) * 2011-04-13 2012-10-17 上海医药工业研究院 用于制备利奈唑胺的中间体及其制备方法
CN102766106A (zh) * 2011-05-03 2012-11-07 江苏豪森医药集团有限公司 利奈唑胺的新晶型及其制备方法
CN102399200B (zh) * 2011-12-14 2013-12-04 浙江新东港药业股份有限公司 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
EP2852580A1 (en) 2012-01-24 2015-04-01 Jubilant Life Sciences Ltd. Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
CN102643245A (zh) * 2012-04-10 2012-08-22 杭州华东医药集团生物工程研究所有限公司 一种利奈唑胺晶型及其制备方法
EP2917189B1 (en) 2012-11-09 2016-08-17 Synthon BV Process for making linezolid
WO2019097242A1 (en) * 2017-11-16 2019-05-23 Persica Pharmaceuticals Ltd. Linezolid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
KR100530297B1 (ko) * 1996-04-11 2005-11-22 파마시아 앤드 업존 캄파니 엘엘씨 옥사졸리디논의 제조 방법
EP1028940B1 (en) * 1997-11-07 2007-04-18 Pharmacia & Upjohn Company LLC Process to produce oxazolidinones

Also Published As

Publication number Publication date
KR20070087178A (ko) 2007-08-27
EE200200420A (et) 2003-12-15
AR027261A1 (es) 2003-03-19
KR20020072300A (ko) 2002-09-14
ES2242728T3 (es) 2005-11-16
JP2003522175A (ja) 2003-07-22
DE60111497T2 (de) 2006-05-18
AU3275501A (en) 2001-08-14
WO2001057035A1 (en) 2001-08-09
JP5235256B2 (ja) 2013-07-10
AU782138B2 (en) 2005-07-07
CN1394207A (zh) 2003-01-29
NO323459B1 (no) 2007-05-14
BR0107667A (pt) 2002-10-08
CA2395603C (en) 2010-03-23
PE20011086A1 (es) 2001-10-04
EP1255754A1 (en) 2002-11-13
EP1255754B1 (en) 2005-06-15
HK1051196A1 (en) 2003-07-25
CA2395603A1 (en) 2001-08-09
NO20023654L (no) 2002-08-01
NZ520541A (en) 2004-02-27
KR100864745B1 (ko) 2008-10-22
NO20023654D0 (no) 2002-08-01
MXPA02007471A (es) 2002-12-13
PT1255754E (pt) 2005-11-30
CN1221547C (zh) 2005-10-05
NO20065836L (no) 2002-08-01
MY122829A (en) 2006-05-31
KR100781815B1 (ko) 2007-12-03
TWI297687B (en) 2008-06-11
EE05197B1 (et) 2009-08-17
ZA200205162B (en) 2003-09-29
CZ302292B6 (cs) 2011-02-09
DE60111497D1 (de) 2005-07-21
CZ20022635A3 (cs) 2002-10-16
ATE297920T1 (de) 2005-07-15
PL356433A1 (en) 2004-06-28
CO5261555A1 (es) 2003-03-31
HUP0301076A2 (hu) 2003-08-28
IL151010A0 (en) 2003-02-12
SK9942002A3 (en) 2002-11-06
EA004434B1 (ru) 2004-04-29
SK287025B6 (sk) 2009-10-07
SI1255754T1 (sl) 2005-12-31
EA200200819A1 (ru) 2003-02-27
HUP0301076A3 (en) 2004-06-28
KR20080044358A (ko) 2008-05-20

Similar Documents

Publication Publication Date Title
DE60111497D1 (de) Linezolid-krystall form ii
DE60129488D1 (de) Anzeigegerät
DE60127364D1 (de) Antriebsvorrichtung
DE60132478D1 (de) Antriebsvorrichtung
DE60109777D1 (de) Plattenlaufwerk
CY2009001I1 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
DE60125415D1 (de) Formeinsatz
FR2810866B1 (fr) Presentoir
DE60011747D1 (de) Flüssigkristallanzeige
DE60101983D1 (de) Flüssigkristallanzeige
DE60114822D1 (de) Pen-pet-pen-polymerfilm
DE60112167D1 (de) Vibrator
DE50101124D1 (de) Antriebsvorrichtung
DE60136991D1 (de) Flüssigkristallprojektor
DE60111288D1 (de) Flüssigkristallanzeige
DE50109358D1 (de) Flüssigkristall-Anzeige
DE60114278D1 (de) Kalenderuhr
DE60200268D1 (de) Einkristallzüchtungsverfahren
FIU20000076U0 (fi) Kalanteri
DE50106225D1 (de) Antriebsvorrichtung
FI20000399A0 (fi) Kalanteri
DE50103447D1 (de) Antriebsvorrichtung
FR2817889B1 (fr) Coffrage
DE50101941D1 (de) Dermatologie-handlupe
FI4742U1 (fi) Kalanteri